Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 71186-006

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 71186-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vilvet Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chlordiazepoxide 01)

Chemical structure of Chlordiazepoxide Hydrochloride, showing the molecular arrangement with chlorine and hydrochloride components as part of the structure.*

FDA Label Image

Chemical Structure (Chlordiazepoxide 02)

Chemical structure diagram of Clidinium Bromide showing its molecular bonds and arrangement, as part of the active ingredients in the product Chlordiazepoxide Hydrochloride and Clidinium Bromide by Vilvet Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel (100 Capsule Bottle Label)

Label of Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules, each containing 5 mg and 2.5 mg respectively. The label indicates a package size of 100 capsules and is manufactured by Vilvet Pharmaceuticals Inc. It includes dosage instructions, storage conditions, and safety warnings. The NDC number is 71186-006-35.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.